Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biopol Chemicals's Enterprise Value is ₹1,136.2 Mil.
Biopol Chemicals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Biopol Chemicals's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biopol Chemicals's Enterprise Value is ₹1,136.2 Mil.
Biopol Chemicals does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Biopol Chemicals's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Biopol Chemicals's Enterprise Value is ₹1,136.2 Mil.
Biopol Chemicals does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Biopol Chemicals's EV-to-Revenue at this moment.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Biopol Chemicals's Enterprise Value is ₹1,136.2 Mil.
Biopol Chemicals does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Biopol Chemicals's EV-to-FCF at this moment.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Biopol Chemicals (NSE:BIOPOL) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
Biopol Chemicals Enterprise Value Related Terms
Biopol Chemicals Enterprise Value Historical Data
* Premium members only.
The historical data trend for Biopol Chemicals's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals Enterprise Value Chart
Biopol Chemicals Annual Data
Trend
Mar24
Mar25
Mar26
Enterprise Value
0.00
0.00
1,128.63
Biopol Chemicals Semi-Annual Data
Mar24
Mar25
Mar26
Enterprise Value
0.00
0.00
1,128.63
NSE:BIOPOL vs LIN, SHW, ECL: Enterprise Value Comparison
For the Specialty Chemicals subindustry, Biopol Chemicals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biopol Chemicals Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Biopol Chemicals's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Biopol Chemicals's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Biopol Chemicals's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ₹1,136.2 Mil mean?
Biopol Chemicals (NSE:BIOPOL) has a Enterprise Value of ₹1,136.2 Mil as of Jul. 23, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Biopol Chemicals and its competitors.
Is Biopol Chemicals' Enterprise Value too high?
Biopol Chemicals' current Enterprise Value is ₹1,136.2 Mil. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' Enterprise Value compare to LIN and SHW?
Biopol Chemicals' Enterprise Value of ₹1,136.2 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Biopol Chemicals and its competitors. Biopol Chemicals's current Enterprise Value is ₹1,136.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current Enterprise Value of ₹1,136.2 Mil. The current Enterprise Value is ₹1,136.2 Mil. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current Enterprise Value is ₹1,136.2 Mil as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressStreet No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score
Get the complete analysis for NSE:BIOPOL
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BIOPOL has been successfully added to your 
